Neonatal withdrawal syndrome after chronic maternal drinking of mate

Therapeutic Drug Monitoring

Volumn 29, Issue 1, 2007, Pages 127-129

  Martín, Itziar ^a   López Vílchez, María Ángeles ^a   Mur, Antonio ^a,b   García Algar, Óscar ^a,b   Rossi, Silvia ^c   Marchei, Emilia ^c   Pichini, Simona ^c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Caffeine; Mate; Newborn; Theobromine; Withdrawal

Indexed keywords

CAFFEINE; METHYLXANTHINE DERIVATIVE; THEOBROMINE;

APGAR SCORE; ARTICLE; BREAST MILK; CASE REPORT; CORD SERUM; FEMALE; HAIR ANALYSIS; HUMAN; INFANT; IRRITABILITY; LABORATORY TEST; MECONIUM; MOTHER FETUS RELATIONSHIP; MUSCLE HYPERTONIA; NERVOUSNESS; PATHOLOGICAL CRYING; PERINATAL DRUG EXPOSURE; PLACENTA; PRENATAL EXPOSURE; PRIORITY JOURNAL; REFLEX DISORDER; TENDON REFLEX; URINALYSIS; WITHDRAWAL SYNDROME;

BEVERAGES; BREAST FEEDING; CAFFEINE; FEMALE; HUMANS; ILEX PARAGUARIENSIS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; PLANT EXTRACTS; PLANT LEAVES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; THEOBROMINE;

EID: 33847149765     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31803257ed     Document Type: Article

References (25)

1. Santos IS, Matijasevich A, Valle CJ. Maté drinking during pregnancy and risk of preterm and small for gestational age birth. J Nutr. 2005;135:1120-1123.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Coffee, Tea, Maté, Methylxanthines and Methylglyoxal. Vol. 51. Lyon, France: IARC; 1991.
3. Marchei E, Pellegrini M, Pacifici R, et al. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for methylxanthines and taurine in dietary supplements. J Pharm Biomed Anal. 2005;37:499-507.
4. Kaltenbach K, Finnegan LP. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol. 1986;8:353-355.
5. Leviton A, Cowan L. A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol. 2002;40:1271-1310.
6. Matijasevich A, Santos IS, Barros FC. Does caffeine consumption during pregnancy increase the risk of fetal mortality? A literature review. Cad Saude Publica. 2005;21:1676-1684.
7. Bech BH, Nohr EA, Vaeth M, et al. Coffee and fetal death: a cohort study with prospective data. Am J Epidemiol. 2005;162:983-990.
8. Matijasevich A, Barros FC, Santos IS, et al. Maternal caffeine consumption and fetal death: a case control study in Uruguay. Paediatr Perinat Epidemiol. 2006;20:100-109.
9. Eskenazi B, Stapleton AL, Kharrazi M, et al. Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration. Epidemiology. 1999;10:242-249.
10. Wisborg K, Kesmodel U, Bech BH, et al. Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life: prospective study. Br Med J. 2003;326:420.
11. Chiaffarino F, Prazzini F, Chatenoud L, et al. Coffee drinking and risk of preterm birth. Eur J Clin Nutr. 2006;60: 610-613.
12. Vik T, Bakketeig LS, Trygg KU, et al. High caffeine consumption in the third trimester of pregnancy: gender-specific effects on fetal growth. Paediatr Perinat Epidemiol. 2003;17:324-331.
13. McGowan JD, Altman RE, Kanto WP. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J. 1988;81:1092-1094.
14. Khanna NN, Somani SM. Maternal coffee drinking and unusually high concentrations of caffeine in the newborn. J Toxicol Clin Toxicol. 1984;22:473-483.
15. McKim EM. Caffeine and its effects on pregnancy and the neonate. J Nurse Midwifery. 1991;36:226-231.
16. Balat O, Balat O, Ugur MG, et al. The effect of smoking and caffeine on the fetus and placenta in pregnancy. Clin Exp Obstet Gynecol. 2003;30:57-59.
17. Thomson AH, Kerr S, Wright S. Population pharmacokinetics of caffeine in neonates and young infants. Ther Drug Monit. 1996;18:245-253.
18. de Wildt SN, Kerkvliet KT, Wezenberg MG, et al. Use of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther Drug Monit. 2001;23:250-254.
19. Dempsey DA, Partridge JC, Jones RT, et al. Cocaine, nicotine, caffeine and metabolite plasma concentration in neonates. J Anal Toxicol. 1998;22:220-224.
20. Baranowski J, Pochopien G, Baranowska I. Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. J Chromatogr B. 1998;707:317-321.
21. Bada HS, Khanna NN, Somani SM, et al. Interconversion of theophylline and caffeine in newborn infants. J Pediatr. 1979;94:993-995.
22. Stavric B. Methylxanthines: toxicity to humans. 1. Theophylline. Food Chem Toxicol. 1988;26:541-565.
23. Stavric B. Methylxanthines: toxicity to humans. 2. Caffeine. Food Chem Toxicol. 1988;26:645-662.
24. Stavric B. Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines. Food Chem Toxicol. 1988;26:725-733.
25. Koren G. Caffeine during pregnancy? In moderation. Can Fam Phys. 2000;46:801-803.